276 related articles for article (PubMed ID: 20859201)
1. The current state of recombinant allergens for immunotherapy.
Pauli G; Malling HJ
Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):575-81. PubMed ID: 20859201
[TBL] [Abstract][Full Text] [Related]
2. Allergen-specific immunotherapy with recombinant allergens.
Pauli G; Malling HJ
Curr Top Microbiol Immunol; 2011; 352():43-54. PubMed ID: 21404096
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials with recombinant allergens--three perspectives: industry.
Narkus A; Kniest F; Menzel A; Meyer H; Sprung V
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():270-5; discussion 275-8. PubMed ID: 20799471
[No Abstract] [Full Text] [Related]
4. Recombinant allergens for immunotherapy.
Valenta R; Niederberger V
J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
[TBL] [Abstract][Full Text] [Related]
5. Allergen immunotherapy for birch pollen-allergic patients: recent advances.
Moingeon P; Floch VB; Airouche S; Baron-Bodo V; Nony E; Mascarell L
Immunotherapy; 2016 May; 8(5):555-67. PubMed ID: 27140409
[TBL] [Abstract][Full Text] [Related]
6. Specific immunotherapy, one century later.
Passalacqua G; Bush RK
Curr Opin Allergy Clin Immunol; 2011 Dec; 11(6):551-3. PubMed ID: 21971328
[No Abstract] [Full Text] [Related]
7. Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives.
Purohit A; Niederberger V; Kronqvist M; Horak F; Grönneberg R; Suck R; Weber B; Fiebig H; van Hage M; Pauli G; Valenta R; Cromwell O
Clin Exp Allergy; 2008 Sep; 38(9):1514-25. PubMed ID: 18564326
[TBL] [Abstract][Full Text] [Related]
8. Recombinant allergens for specific immunotherapy.
Cromwell O; Häfner D; Nandy A
J Allergy Clin Immunol; 2011 Apr; 127(4):865-72. PubMed ID: 21377719
[TBL] [Abstract][Full Text] [Related]
9. Clinical trials with recombinant allergens: research studies?
Pauli G
Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():257-64; discussion 264-5. PubMed ID: 20799469
[No Abstract] [Full Text] [Related]
10. Allergen-related approaches to immunotherapy.
Rolland JM; Gardner LM; O'Hehir RE
Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with recombinant molecules for allergy vaccination.
Cromwell O; Niederberger V; Horak F; Fiebig H
Curr Top Microbiol Immunol; 2011; 352():27-42. PubMed ID: 21562972
[TBL] [Abstract][Full Text] [Related]
12. The impact of molecular biology on allergen immunotherapy.
Bush RK
Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):557-8. PubMed ID: 21030836
[No Abstract] [Full Text] [Related]
13. Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients.
Marogna M; Spadolini I; Massolo A; Zanon P; Berra D; Chiodini E; Canonica WG; Passalacqua G
Ann Allergy Asthma Immunol; 2007 Mar; 98(3):274-80. PubMed ID: 17378260
[TBL] [Abstract][Full Text] [Related]
14. Epicutaneous immunotherapy.
Scheurer S; Toda M
Allergol Immunopathol (Madr); 2017 Dec; 45 Suppl 1():25-29. PubMed ID: 29108765
[No Abstract] [Full Text] [Related]
15. Allergen immunotherapy: where is it now?
Nelson HS
J Allergy Clin Immunol; 2007 Apr; 119(4):769-79. PubMed ID: 17337297
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in immunotherapy for allergic diseases.
El-Qutob D; Mencia G; Fernandez-Caldas E
Recent Pat Inflamm Allergy Drug Discov; 2014 Jan; 8(1):24-35. PubMed ID: 24237114
[TBL] [Abstract][Full Text] [Related]
17. [New concepts in therapy of type I allergic diseases].
Valenta R; Steinberger P; Vrtala S; Grote M; Laffer S; Sperr WR; Valent P; Kraft D; Scheiner O
Wien Klin Wochenschr; 1993; 105(23):682-6. PubMed ID: 7508663
[TBL] [Abstract][Full Text] [Related]
18. Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens.
Valenta R; Linhart B; Swoboda I; Niederberger V
Allergy; 2011 Jun; 66(6):775-83. PubMed ID: 21352238
[TBL] [Abstract][Full Text] [Related]
19. Allergen-specific immunotherapy with recombinant grass pollen allergens.
Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
[TBL] [Abstract][Full Text] [Related]
20. Immunological mechanisms of allergen-specific immunotherapy.
Jutel M; Akdis CA
Allergy; 2011 Jun; 66(6):725-32. PubMed ID: 21466562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
